Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Clinical trial NCT04782687 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04782687
Sponsor: US Oncology Research
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Myeloma Multiple Kahler Disease Myeloma, Plasma Cell Myeloma-Multiple Myelomatosis Plasma Cell Myeloma

Start date: 2021-09-10
Primary completion: 2026-05-31
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.